Chugai Pharmaceutical Co. Ltd.

Pharmaceuticals
Japan
2016 Revenue (US$ Millions)$4,205
Revenue Growth (%)-1.42%
Net Income (US$ Millions)$458
Earnings Per Share (US$)$0.84
EPS Growth Rate (%)-12.36%
Profit Margin10.90%
Total Equity (US$ Millions)$5,519
Return on Equity (%)8.56%
Long Term Debt (US$ Millions)$4
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$6,894
Current Assets (US$ Millions)$4,948
Current Liabilities (US$ Millions)$1,057
Cost of Goods Sold (US$ Millions)$2,120
Inventory Turnover1.43